Beyond Air, Inc. key statistics and ratios
In fiscal 2026, Beyond Air, Inc. had a net margin of -433.0%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Net margin | −84.9% | <−999% | <−999% | <−999% | <−999% | −433.0% | −435.7% |
| Return on equity | −162.9% | −180.3% | −94.2% | — | — | — | — |
| Return on assets | −69.6% | −108.2% | −67.3% | −123.6% | −107.2% | −101.6% | −98.1% |
| R&D as % of revenue | 50.9% | 766.1% | >999% | >999% | 455.0% | 133.4% | 118.6% |
| SG&A as % of revenue | — | — | — | >999% | 702.2% | 248.1% | 250.4% |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Net margin | <−999% | <−999% | −697.4% | −437.0% | −436.7% | −334.4% | −539.2% | −448.8% |
| R&D as % of revenue | 574.6% | 280.3% | 282.8% | 175.3% | 134.8% | 110.7% | 119.3% | 110.8% |
| SG&A as % of revenue | 897.6% | 721.3% | 337.2% | 266.3% | 270.2% | 203.6% | 261.6% | 275.9% |
Financial health
- Short-term assets cover short-term liabilities $23m of assets due within a year against $7m of liabilities due within a year.
- Short-term assets cover long-term liabilities $23m short-term assets against $23m of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Operating income of −$28m against $4m of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Compare with peers
- Invo Fertility, Inc. statistics
- Anbio Biotechnology statistics
- Nuwellis, Inc. statistics
- Milestone Scientific Inc. statistics
- Neuroone Medical Technologies Corp statistics
Head to head: IVF vs XAIRNNNN vs XAIRNUWE vs XAIR
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies